Crossmark

mRNA-based cancer therapeutics

Crossref DOI link: https://doi.org/10.1038/s41568-023-00586-2

Published Online: 2023-06-13

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Chuang https://orcid.org/0000-0002-2445-0845
Shi, Qiangqiang

Huang, Xiangang

Koo, Seyoung

Kong, Na

Tao, Wei https://orcid.org/0000-0002-4277-3728
License Information

Text and Data Mining valid from 2023-06-13

Version of Record valid from 2023-06-13
More Information

Article History

Accepted: 26 April 2023

First Online: 13 June 2023

Competing interests

: The authors declare no competing interests.